Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
Clinical trial NCT02575222 · COMPLETED
Trial details
- NCT number
- NCT02575222
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2020-06-09
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.